Addictions and Mental Health
Addictions and Mental Health Events hosted by the IHE
19 November 2015
Strengthening Mental Health Services for Children and Families was the 14th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
4 – 6 November 2014
The Institute of Health Economics, in collaboration with the Government of Alberta and with support from Alberta Health Services (AHS), hosted the Consensus Development Conference on Improving Mental Health Transitions in Edmonton, Alberta. This conference, with its unique and compelling "jury trial" format, examined the following questions:
- What is the effectiveness of current interventions for adults with SPMI?
- What is the evidence for the role of other support systems, including primary care in effective interventions?
- What are the effective systems for supporting people with SPMI?
- What information tools are required for high quality system management?
- What further research is needed?
23 – 25 September 2013
IHE hosted the First International Conference on Prevention of FASD, September 23 - 25, 2013 in Edmonton, Alberta. More than 800 people were in attendance, including global experts and leaders in the health system, government, and the academic and business communities.
18 - 20 September 2013
IHE held the first-ever Consensus Development Conference on Legal Issues of FASD September 18 – 20, 2013 in Edmonton, Alberta. This conference, with its unique and compelling "jury trial" format, examined the following questions:
- What are the implications of FASD for the legal system?
- Is there a need for enhanced efforts to identify people with FASD, and how can these efforts be achieved?
- How can the criminal justice system respond more effectively to those with FASD?
- How can family courts and the family/child welfare legal system address the specific needs of people with FASD?
- What are the best practices for guardianship, trusteeship and social support in a legal context?
- What legal measures are there in different jurisdictions to contribute to the prevention of FASD, and what are the ethical and economic implications of these measures?
18 July 2010
In order to better understand Mental Health & Addictions in the Workplace, the Pacific Northwest Economic (PNWER) Health Care Working Group hosted a half day session in conjunction with the annual PNWER summit. This session brought together key policy experts, decision makers, clinicians, and business leaders, and provided the opportunity for dialogue around this issue.
7 - 9 October 2009
The IHE Consensus Development Conference on FASD: Across the Lifespan, was held October 7 - 9, 2009 in Edmonton, Alberta. This conference, with its unique and compelling "jury trial" format, examined the following questions:
- What is Fetal Alcohol Spectrum Disorder (FASD) and how is it diagnosed?
- Do we know the prevalence and incidence of FASD in different populations and can the reporting be improved?
- What are the consequences of FASD on individuals, families and society?
- How can FASD be prevented?
- What policy options could more effectively support individuals with FASD and their families across the lifespan?
- What further research into FASD is needed?
15 – 17 October 2008
The Institute of Health Economics (IHE), in collaboration with the Alberta Depression Initiative Project, Alberta Health and Wellness, the Alberta Mental Health Board and the Mental Health Commission of Canada organized a Consensus development conference on Depression in Adults: How to Improve Prevention, Diagnosis and Treatment in Calgary, Alberta in October 2008. This conference, with its unique and compelling "jury trial" format, examined the following questions:
- What is depression and how common is it?
- What are the effects of depression for the individual, family, and society?
- What are the risk factors for depression, and how can prevention of these be improved?
- What are the most appropriate ways for diagnosing depression?
- What are current treatments for depression and what evidence is available for their safety and effectiveness?
- What are the obstacles to effective management of depression and strategies to overcome them?
- What further research is needed in the field?